IFN-treatment of B16-F1 versus B16-F10: relative impact on non-adaptive and T-cell-mediated immune defense in metastatic spread.

Zöller, M

IFN-treatment of B16-F1 versus B16-F10: relative impact on non-adaptive and T-cell-mediated immune defense in metastatic spread. [electronic resource] - Clinical & experimental metastasis - 411-29 p. digital

Publication Type: Journal Article

0262-0898

10.1007/BF01760576 doi


Animals
Cell Line
Cell Survival
H-2 Antigens--immunology
Immunity, Innate
Immunization
Interferon-gamma--pharmacology
Lung Neoplasms--secondary
Lymphocyte Activation--drug effects
Male
Melanoma--immunology
Mice
Neoplasm Metastasis--immunology
T-Lymphocytes--drug effects
Tumor Cells, Cultured--drug effects